Yumei Hao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yumei Hao has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- An Xie
Department of Pharmaceutics, College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
1 shared publication - He Li
Beijing City Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
1 shared publication - Yujia Zhang
State Key Laboratory of Bioactive Substance and Function of Natural Medicines & Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
1 shared publication
Latest Publications
- Open Access
- 13 September 2021
- Published by Springer Nature in Discover Nano
- Vol. 16 (1) , 1-10
Tuning the Toxicity of Reactive Oxygen Species into Advanced Tumor Therapy
The biological functions and toxic effects of reactive oxygen species (ROS) are generally entangled. A large amount of ROS may cause oxidative damage to cell biomolecules, leading to cell death. Tumor treatment can be carried out by using the toxicity of ROS, and various nanosystems related to ROS have been designed. In fact, the level of active oxygen in the biological microenvironment can be regulated in advanced therapeutics via designed nanoscale engineering, which can open up a new direction of treatment with specific simplicity. In this progress report, the authors first introduced how ROS causes cell death. Then, recent studies on converting the inherent toxicity from ROS into advanced treatment tools are highlighted.
- 13 September 2021
- Published by Springer Nature in Discover Nano
- Vol. 16 (1) , 1-10
Open AccessTuning the Toxicity of Reactive Oxygen Species into Advanced Tumor Therapy
The biological functions and toxic effects of reactive oxygen species (ROS) are generally entangled. A large amount of ROS may cause oxidative damage to cell biomolecules, leading to cell death. Tumor treatment can be carried out by using the toxicity of ROS, and various nanosystems related to ROS have been designed. In fact, the level of active oxygen in the biological microenvironment can be regulated in advanced therapeutics via designed nanoscale engineering, which can open up a new direction of treatment with specific simplicity. In this progress report, the authors first introduced how ROS causes cell death. Then, recent studies on converting the inherent toxicity from ROS into advanced treatment tools are highlighted.